Astrana Health
ASTH
149 hedge funds and large institutions have $1.26B invested in Astrana Health in 2021 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 55 increasing their positions, 50 reducing their positions, and 22 closing their positions.
270% more call options, than puts
Call options by funds: $13.7M | Put options by funds: $3.71M
36% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 22
10% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 50
8.28% more ownership
Funds ownership: 30.14% → 38.42% (+8.3%)
5% more funds holding
Funds holding: 142 → 149 (+7)
17% less capital invested
Capital invested by funds: $1.52B → $1.26B (-$262M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$61.6M |
| 2 |
BlackRock
New York
|
+$7.65M |
| 3 |
SW
SteelPeak Wealth
Woodland Hills,
California
|
+$6.78M |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$6.17M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$4.91M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$29.9M |
| 2 |
OAM
Ophir Asset Management
Sydney,
Australia
|
-$8M |
| 3 |
US Bancorp
Minneapolis,
Minnesota
|
-$7.57M |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
-$7.12M |
| 5 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
-$3.95M |
ASTH Hedge Fund Activity: Q4 2021 in Review
149 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Astrana Health (ASTH) for Q4 2021, worth a combined $1.26B — down 17% from $1.52B a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new ASTH positions and 22 closed out — a net gain of 8 holders — while 55 added to existing stakes and 50 trimmed.
The largest buyer was Vanguard Group, adding an estimated $61.6M. The largest seller was Invesco, cutting an estimated $29.9M.
- 149 institutional investors held Astrana Health (ASTH) as of Q4 2021, up from 142 in Q3 2021.
- Funds reported $1.26B of Astrana Health stock for Q4 2021, down 17% quarter-over-quarter.
- 30 funds opened new Astrana Health positions in Q4 2021 and 22 closed out, a net change of +8 holders.
- The largest Astrana Health buyer in Q4 2021 was Vanguard Group, an estimated $61.6M added.
- The largest Astrana Health seller in Q4 2021 was Invesco, an estimated $29.9M sold.
Based on aggregated 13F filings for Q4 2021.